Among patients who developed AKI within 24 hours after enrollment, a urinary [TIMP-2] × [IGFBP7] level greater than 2.0 (ng/mL)2/1000 was associated with greater mortality risk at 30 days when AKI stages were defined by kidney function. This evidence concerns the gene IGFBP7 and acute kidney injury.